# Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery

> **NCT03140033** · PHASE2 · UNKNOWN · sponsor: **Ain Shams Maternity Hospital** · enrollment: 158 (estimated)

## Conditions studied

- Hemorrhage Postpartum

## Interventions

- **DRUG:** Misoprostol Oral Tablet
- **DRUG:** Ranitidine Oral Tablet

## Key facts

- **NCT ID:** NCT03140033
- **Lead sponsor:** Ain Shams Maternity Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03140033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03140033, "Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03140033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*